Common variable immunodeficiency: epidemiology, pathogenesis, clinical manifestations, diagnosis, classification, and management.

R Yazdani, S Habibi, L Sharifi, G Azizi… - … allergology & clinical …, 2019 - europepmc.org
Common variable immunodeficiency (CVID) is a heterogeneous disorder characterized by
hypogammaglobulinemia and increased susceptibility to recurrent bacterial infections. It is …

[HTML][HTML] Current understanding and recent developments in common variable immunodeficiency associated autoimmunity

JD Gereige, PJ Maglione - Frontiers in immunology, 2019 - frontiersin.org
Common variable immunodeficiency (CVID) is the most prevalent symptomatic primary
immunodeficiency and comprises a group of disorders with similar antibody deficiency but a …

[HTML][HTML] Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency

JS Heitmann, C Tandler, M Marconato, A Nelde… - Nature …, 2023 - nature.com
T-cell immunity is central for control of COVID-19, particularly in patients incapable of
mounting antibody responses. CoVac-1 is a peptide-based T-cell activator composed of …

[HTML][HTML] B cell response induced by SARS-CoV-2 infection is boosted by the BNT162b2 vaccine in primary antibody deficiencies

F Pulvirenti, A Fernandez Salinas, C Milito, S Terreri… - Cells, 2021 - mdpi.com
Background: Patients with primary antibody deficiencies are at risk in the current COVID-19
pandemic due to their impaired response to infection and vaccination. Specifically, patients …

[HTML][HTML] Autoimmunity in primary immunodeficiency disorders: an updated review on pathogenic and clinical implications

G Costagliola, S Cappelli, R Consolini - Journal of Clinical Medicine, 2021 - mdpi.com
During the last years, studies investigating the intriguing association between
immunodeficiency and autoimmunity led to the discovery of new monogenic disorders, the …

Autoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management

G Azizi, H Abolhassani, MH Asgardoon… - Expert review of …, 2017 - Taylor & Francis
Introduction: Common variable immunodeficiency (CVID) comprises a large heterogeneous
group of patients with primary antibody deficiency. Areas covered: The affected patients are …

Malignancy in common variable immunodeficiency: a systematic review and meta-analysis

F Kiaee, G Azizi, H Rafiemanesh… - Expert review of …, 2019 - Taylor & Francis
Background: Common variable immunodeficiency (CVID) is the most common clinically
significant primary immunodeficiency (PID) disorder characterized by variable clinical …

Common variable immunodeficiency and liver involvement

J Song, A Lleo, GX Yang, W Zhang, CL Bowlus… - Clinical reviews in …, 2018 - Springer
Common variable immunodeficiency (CVID) is a primary B-cell immunodeficiency disorder,
characterized by remarkable hypogammaglobulinemia. The disease can develop at any age …

[HTML][HTML] The broad spectrum of lung diseases in primary antibody deficiencies

F Cinetto, R Scarpa, M Rattazzi… - European Respiratory …, 2018 - Eur Respiratory Soc
Human primary immunodeficiency diseases (PIDs) represent a heterogeneous group of
more than 350 disorders. They are rare diseases, but their global incidence is more relevant …

Autoimmunity in common variable immunodeficiency: a systematic review and meta-analysis

FS Rizvi, H Zainaldain, H Rafiemanesh… - Expert review of …, 2020 - Taylor & Francis
Objectives: Common variable immunodeficiency (CVID) is the most common symptomatic
inborn error of immunity characterized by variable clinical manifestations. Methods: Web of …